BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 15102714)

  • 1. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program.
    Inoue M; Sakuraba Y; Motegi H; Kubota N; Toki H; Matsui J; Toyoda Y; Miwa I; Terauchi Y; Kadowaki T; Shigeyama Y; Kasuga M; Adachi T; Fujimoto N; Matsumoto R; Tsuchihashi K; Kagami T; Inoue A; Kaneda H; Ishijima J; Masuya H; Suzuki T; Wakana S; Gondo Y; Minowa O; Shiroishi T; Noda T
    Hum Mol Genet; 2004 Jun; 13(11):1147-57. PubMed ID: 15102714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and pathomorphological characteristics of a novel mutant mouse model for maturity-onset diabetes of the young type 2 (MODY 2).
    van Bürck L; Blutke A; Kautz S; Rathkolb B; Klaften M; Wagner S; Kemter E; Hrabé de Angelis M; Wolf E; Aigner B; Wanke R; Herbach N
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E512-23. PubMed ID: 19952346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects.
    Aigner B; Rathkolb B; Herbach N; Hrabé de Angelis M; Wanke R; Wolf E
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E232-40. PubMed ID: 18056790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice.
    Michaud EJ; Culiat CT; Klebig ML; Barker PE; Cain KT; Carpenter DJ; Easter LL; Foster CM; Gardner AW; Guo ZY; Houser KJ; Hughes LA; Kerley MK; Liu Z; Olszewski RE; Pinn I; Shaw GD; Shinpock SG; Wymore AM; Rinchik EM; Johnson DK
    BMC Genomics; 2005 Nov; 6():164. PubMed ID: 16300676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
    Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
    N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online.
    Guazzini B; Gaffi D; Mainieri D; Multari G; Cordera R; Bertolini S; Pozza G; Meschi F; Barbetti F
    Hum Mutat; 1998; 12(2):136. PubMed ID: 10694920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new mouse model of type 2 diabetes, produced by N-ethyl-nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene.
    Toye AA; Moir L; Hugill A; Bentley L; Quarterman J; Mijat V; Hough T; Goldsworthy M; Haynes A; Hunter AJ; Browne M; Spurr N; Cox RD
    Diabetes; 2004 Jun; 53(6):1577-83. PubMed ID: 15161764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Swiss journey through the clinical and genetic characteristics of diabetes in young patients].
    Dussoix P; Tappy L; Philippe J
    Schweiz Med Wochenschr; 1998 Jan; 128(5):162-6. PubMed ID: 9522422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
    Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms?
    Hansen L
    Dan Med Bull; 2003 Nov; 50(4):320-46. PubMed ID: 14694850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period.
    Calderari S; Gangnerau MN; Meile MJ; Portha B; Serradas P
    Pancreas; 2006 Nov; 33(4):412-7. PubMed ID: 17079948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.
    Xu JY; Dan QH; Chan V; Wat NM; Tam S; Tiu SC; Lee KF; Siu SC; Tsang MW; Fung LM; Chan KW; Lam KS
    Eur J Hum Genet; 2005 Apr; 13(4):422-7. PubMed ID: 15657605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of type 2 diabetes mellitus.
    Malecki MT
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S10-21. PubMed ID: 15955369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and analysis of novel R308K mutation in glucokinase of type 2 diabetic patient and its kinetic correlation.
    Yellapu NK; Valasani KR; Pasupuleti SK; Gopal S; Potukuchi Venkata Gurunadha Krishna S; Matcha B
    Biotechnol Appl Biochem; 2014; 61(5):572-81. PubMed ID: 24447076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
    Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
    Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2.
    Loomba-Albrecht LA; Jame M; Bremer AA
    Diabetes Res Clin Pract; 2010 Mar; 87(3):e23-5. PubMed ID: 20015564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in plasma enzyme activities as novel organ-specific disease models.
    Aigner B; Rathkolb B; Klaften M; Sedlmeier R; Klempt M; Wagner S; Michel D; Mayer U; Klopstock T; de Angelis MH; Wolf E
    Exp Physiol; 2009 Apr; 94(4):412-21. PubMed ID: 19151073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity.
    Arden C; Trainer A; de la Iglesia N; Scougall KT; Gloyn AL; Lange AJ; Shaw JA; Matschinsky FM; Agius L
    Diabetes; 2007 Jul; 56(7):1773-82. PubMed ID: 17389332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Now and future of mouse mutagenesis for human disease models.
    Gondo Y
    J Genet Genomics; 2010 Sep; 37(9):559-72. PubMed ID: 20933210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.